Krystal Biotech Inc (KRYS)

Exchange
NASDAQ
Symbol
KRYS
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United States. The company is headquartered in Pittsburgh, Pennsylvania.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    184.22
  • High
    194.59
  • Low
    182.57
  • Close
    183.09
  • Volume
    610,115

Financial ratios

Mar 31, 2024

Activity ratios
Inventory turnover
8.87
Receivables turnover
2.20
Payables turnover
18.26
Working capital turnover
0.18
Days of inventory on hand (DOH)
41.17
Days of sales outstanding (DSO)
165.91
Number of days of payables
19.99
Fixed asset turnover
0.64
Total asset turnover
0.12
 Liquidity ratios
Current ratio
12.66
Quick ratio
12.29
Cash ratio
11.31
Cash conversion cycle
187.09
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.07
Interest coverage
-2.70
 Profitability ratios
Gross profit margin
4.28%
Operating profit margin
-66.11%
Pretax margin
57.84%
Net profit margin
55.92%
Operating return on assets (Operating ROA)
-7.92%
Return on assets (ROA)
6.70%
Return on total capital
-8.46%
Return on equity (ROE)
7.15%